| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 652 |
| 1 | ACETAMINOPHEN | 472 |
| 2 | INFLIXIMAB | 429 |
| 3 | RITUXIMAB | 418 |
| 4 | METHOTREXATE SODIUM | 411 |
| 5 | TOCILIZUMAB | 399 |
| 6 | LEFLUNOMIDE | 390 |
| 7 | ERGOCALCIFEROL | 381 |
| 8 | ABATACEPT | 374 |
| 9 | ACETAMINOPHEN 500MG | 373 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FOSCARBIDOPA/FOSLEVODOPA | 291 | 0.0330 |
| 1 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 18 | 0.0274 |
| 2 | KETAMINE HYDROCHLORIDE | 116 | 0.0226 |
| 3 | 12%AZELAIC ACID | 18 | 0.0215 |
| 4 | CORTISONE ACETATE | 252 | 0.0202 |
| 5 | APOMORPHINE HYDROCHLORIDE | 31 | 0.0184 |
| 6 | BOTULINUM TOXIN TYPE A | 233 | 0.0182 |
| 7 | AZELAIC ACID | 18 | 0.0182 |
| 8 | HYDROCORTISONE BUTYRATE | 35 | 0.0177 |
| 9 | PSEUDOEPHEDRINE HCL | 184 | 0.0168 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 754 |
| 1 | Prostacycline Vasodilator [EPC] | 654 |
| 2 | Corticosteroid [EPC] | 558 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 492 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 442 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 408 |
| 6 | Antirheumatic Agent [EPC] | 390 |
| 7 | Vitamin C [EPC] | 388 |
| 8 | Provitamin D2 Compound [EPC] | 381 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 374 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 221 | 0.3212 |
| 1 | Human Immunoglobulin G [EPC] | 362 | 0.0172 |
| 2 | Provitamin D2 Compound [EPC] | 381 | 0.0128 |
| 3 | Endoglycosidase [EPC] | 17 | 0.0092 |
| 4 | Interleukin-17A Antagonist [EPC] | 313 | 0.0084 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 31 | 0.0062 |
| 6 | Vitamin B6 Analog [EPC] | 2 | 0.0055 |
| 7 | beta3-Adrenergic Agonist [EPC] | 251 | 0.0053 |
| 8 | Prostacycline Vasodilator [EPC] | 654 | 0.0047 |
| 9 | Human C1 Esterase Inhibitor [EPC] | 18 | 0.0046 |